Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-2.14 Insider Own0.10% Shs Outstand121.15M Perf Week2.67%
Market Cap3.91B Forward P/E- EPS next Y-2.25 Insider Trans- Shs Float120.85M Perf Month24.22%
Income-238.50M PEG- EPS next Q-0.66 Inst Own99.20% Short Float18.32% Perf Quarter32.80%
Sales5.40M P/S724.88 EPS this Y-71.80% Inst Trans0.02% Short Ratio8.34 Perf Half Y-1.31%
Book/sh4.92 P/B6.57 EPS next Y4.30% ROA-54.70% Target Price41.73 Perf Year42.59%
Cash/sh4.86 P/C6.65 EPS next 5Y15.30% ROE-58.50% 52W Range16.64 - 42.49 Perf YTD12.03%
Dividend- P/FCF- EPS past 5Y-43.90% ROI- 52W High-24.48% Beta3.91
Dividend %- Quick Ratio15.30 Sales past 5Y- Gross Margin74.50% 52W Low92.84% ATR1.66
Employees340 Current Ratio15.40 Sales Q/Q13407.70% Oper. Margin- RSI (14)59.14 Volatility6.16% 5.86%
OptionableYes Debt/Eq0.00 EPS Q/Q-57.80% Profit Margin- Rel Volume0.22 Prev Close32.31
ShortableYes LT Debt/Eq0.00 EarningsFeb 06 AMC Payout- Avg Volume2.65M Price32.09
Recom2.30 SMA206.92% SMA5013.36% SMA2002.42% Volume40,114 Change-0.68%
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Jan-14-17 08:25AM  Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016 at Motley Fool
Jan-08-17 12:12PM  Top Stocks to Buy in 2017 at Motley Fool
11:43AM  3 Companies Whose Sales Could Double in 2017 at Motley Fool
Jan-06-17 09:10AM  Acadia Pharmaceuticals' Alzheimer's Data Raises Some Questions at Motley Fool
Jan-05-17 04:51PM  3 ideas to improve waiting for your trades
11:13AM  #1 issue top traders want to fix in 2017 on our prop desk
09:13AM  The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle
Jan-04-17 06:17PM  Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today at Motley Fool +11.02%
04:43PM  Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today at Motley Fool
09:15AM  Biotech Stocks to Watch in 2017 ACADIA Pharmaceuticals and Exelixis Accesswire
Jan-03-17 09:00AM  ACADIA Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017 Business Wire
Dec-28-16 07:18AM  Vetr Still Bullish On Acadia Despite Downgrade
Dec-27-16 08:52AM  4 Biotech Stocks to Buy in January at Motley Fool
Dec-24-16 09:51AM  3 Companies Whose Revenue Could Double in 2017 at Motley Fool
Dec-21-16 10:07AM  ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint
09:15AM  Today's Reports on Biotech Movers ACADIA Pharmaceuticals and Conatus Pharmaceuticals Accesswire
Dec-20-16 11:22PM  Acadia Jumps Following Phase II Alzheimer's Study at Investopedia +12.35%
02:52PM  Why ACADIA Pharmaceuticals Inc. Is Soaring Today at Motley Fool
12:16PM  Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Managers Top Stock Picks for 2017 at Insider Monkey
09:48AM  Acadia Pharma Takes Low Road to Justify Drug Push Into Alzheimer's Psychosis
09:22AM  UPDATE 1-Acadia says Alzheimer's disease psychosis drug clears study
08:30AM  ACADIA Pharmaceuticals Conference Call to Discuss Top-Line Results From Phase II Study With Pimavanserin for AD Psychosis scheduled for 8:30 am ET today
07:40AM  Alzheimer's disease psychosis drug clears mid-stage study -Acadia
07:26AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  ACADIA Pharmaceuticals Announces Positive Top-Line Results From Phase II Study of Pimavanserin for Alzheimers Disease Psychosis Business Wire
Dec-19-16 11:26AM  ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom? at Motley Fool
10:25AM  ACADIA Pharmaceuticals, Inc. Value Analysis (NASDAQ:ACAD) : December 19, 2016
Dec-16-16 04:59PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
07:10AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 16, 2016
Dec-10-16 11:05AM  3 Beaten-Up Biotech Stocks: Are They Bargains? at Motley Fool
Dec-06-16 08:16AM  What's behind put volume in Acadia
Dec-05-16 09:01AM  Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November at Motley Fool
07:06AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 5, 2016
Dec-01-16 09:00AM  ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Major Depressive Disorder Business Wire
Nov-30-16 12:34PM  3 Biotechs With Save-the-Date Catalysts on Tap at Motley Fool
Nov-28-16 08:42AM  Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD) at Insider Monkey
Nov-23-16 10:29AM  5 Biotech Stocks George Soros Is Buying at Motley Fool +5.61%
07:32AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : November 23, 2016
Nov-21-16 07:03AM  Ready to Get In on Biotech? Check Out These 3 Stocks at Motley Fool
Nov-16-16 01:04PM  ACADIA PHARMACEUTICALS INC Financials
09:16AM  ACADIA Starts Phase II Schizophrenia Study on Pimavanserin
08:15AM  Blog Coverage Viking Presents New Clinical Data on VK2809 Accesswire
Nov-15-16 03:19PM  Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks Prospects at Insider Monkey
09:00AM  ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia Business Wire
Nov-11-16 04:08PM  Acadia Faces Education Battle With Parkinson's Drug: Goldman
07:53AM  Coverage initiated on ACADIA Pharmaceuticals by Goldman
07:14AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : November 11, 2016
Nov-10-16 11:56AM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : November 10, 2016
Nov-09-16 10:16AM  ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 +7.56%
Nov-08-16 05:41PM  Here's What Caused ACADIA Pharmaceuticals to Drop 27% in October at Motley Fool +16.75%
03:37PM  Acadia Shares Soar as Nuplazid Sales Easily Top Estimates
11:40AM  Why Acadia Pharmaceuticals Stock Is Surging Today at Motley Fool
11:05AM  Acadia Pharmaceuticals Jumps on Incredible Earnings
10:55AM  Acadia's Valuation Looks Pretty Attractive Right Now: Bank Of America Upgrades To Buy
08:15AM  Analysts' Actions -- Bank of America, Depomed, Hertz, AT&T and More
Nov-07-16 08:37PM  Edited Transcript of ACAD earnings conference call or presentation 7-Nov-16 10:00pm GMT +5.99%
05:48PM  Acadia reports 3Q loss
05:01PM  Acadia Pharma's sales come twice as much as expected at MarketWatch
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:36PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:05PM  ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results Business Wire
07:07AM  Q3 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
Nov-04-16 04:39PM  Arena (ARNA) Q3 Earnings: Will the Stock Pull a Surprise?
03:57PM  Will Kite Pharma (KITE) Stock Surprise Post Q3 Earnings?
08:54AM  Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More
Nov-03-16 06:27PM  What to Expect from Repros (RPRX) This Earnings Season -5.14%
09:00AM  ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia Business Wire
Nov-02-16 09:50AM  9 Biotech Stocks to Put on Your Radar at Kiplinger
Nov-01-16 09:00AM  ACADIA Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 7, 2016 Business Wire
Oct-31-16 09:23AM  ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?
09:00AM  ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimers Disease Agitation Business Wire
Oct-28-16 08:36AM  3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock at Motley Fool
Oct-19-16 10:40AM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : October 19, 2016
Oct-11-16 09:00AM  ACADIA Pharmaceuticals Receives California Life Sciences Associations 2016 Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID Business Wire
Oct-06-16 08:43PM  These 2 Biotechs Could Vanish by 2018 at Motley Fool
Oct-03-16 03:13PM  3 Top Biotech Stocks to Buy in October at Motley Fool
Sep-29-16 09:00AM  The Market In 5 Minutes: OPEC's Deal And Gary Johnson's Moment
08:31AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : September 29, 2016
Sep-23-16 04:07PM  Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails
Sep-22-16 04:40PM  A Critical Couple of Months for Acadia Pharmaceuticals at Motley Fool
Sep-20-16 09:00AM  ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016 Business Wire
Sep-19-16 11:07AM  ACADIA Pharmaceuticals, Inc. Value Analysis (NASDAQ:ACAD) : September 19, 2016
09:00AM  ACADIA Pharmaceuticals Sponsors National Parkinson Foundations Caregiver Summit Business Wire
Sep-16-16 08:19AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : September 16, 2016
Sep-12-16 07:54AM  3 Stocks Begging for a Buyout at Motley Fool +5.18%
Sep-11-16 08:40AM  Why ACADIA Pharmaceuticals Tumbled 13.3% in August at Motley Fool
Sep-10-16 12:09PM  3 Mid-Cap Healthcare Stocks You Can Buy Right Now at Motley Fool
Sep-09-16 10:59AM  5 Stocks to Trade for Big Breakout Gains -6.71%
Sep-06-16 09:00AM  ACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2016 Business Wire
Sep-04-16 07:50AM  Better Buy: ACADIA Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc. at Motley Fool
Sep-01-16 08:05AM  3 Stocks That Could Make You Rich at Motley Fool
Aug-28-16 06:49AM  3 Stocks Up Over 1,000% in the Past 5 Years at Motley Fool
Aug-25-16 08:05AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 25, 2016
07:18AM  CFO Moves: Acadia Pharmaceuticals, Liberty Global at The Wall Street Journal
Aug-24-16 04:23PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -5.53%
09:00AM  ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer Business Wire
Aug-23-16 04:40PM  ACADIA Pharmaceuticals Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
03:41PM  3 Biotech Stocks With Explosive Upside Potential at Motley Fool
Aug-22-16 10:59AM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : August 22, 2016
Aug-15-16 10:01AM  Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares at Insider Monkey
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer's disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baity GlennEVP AND GCDec 28Option Exercise1.625,5008,91077,063Dec 29 05:09 PM
Baity GlennEVP AND GCDec 27Option Exercise1.559,80015,19081,363Dec 29 05:09 PM
Baity GlennEVP AND GCDec 27Sale30.469,800298,47471,563Dec 29 05:09 PM
Baity GlennEVP AND GCDec 20Option Exercise1.5510,00015,50081,563Dec 21 07:03 PM
Baity GlennEVP AND GCDec 20Sale30.0010,000300,00171,563Dec 21 07:03 PM
Baity GlennEVP AND GCDec 19Option Exercise1.648,63514,16171,563Dec 21 07:03 PM
Baity GlennEVP AND GCNov 10Option Exercise1.5510,20015,81073,121Nov 14 07:00 PM
Baity GlennEVP AND GCNov 10Sale30.0710,200306,68762,921Nov 14 07:00 PM
HARRIGAN EDMUNDDirectorAug 16Buy32.971,00032,9701,000Aug 18 05:14 PM
BAKER BROS. ADVISORS LPDirectorAug 10Buy33.001,303,03042,999,99022,337,275Aug 12 04:08 PM
Baity GlennEVP AND GCJul 12Option Exercise6.7811,94380,97474,864Jul 13 06:28 PM
Baity GlennEVP AND GCJul 12Sale35.0011,943418,03162,921Jul 13 06:28 PM
Baity GlennEVP AND GCJul 11Option Exercise6.784,05727,50666,978Jul 13 06:28 PM
Baity GlennEVP AND GCJul 11Sale35.004,057142,00162,921Jul 13 06:28 PM
GRAY MARY ANNDirectorJun 07Option Exercise9.0416,637150,398149,476Jun 09 05:28 PM
Iversen Leslie LDirectorApr 18Option Exercise1.7533,69758,97069,824Apr 20 05:37 PM
Iversen Leslie LDirectorApr 18Sale33.5333,6971,129,99936,127Apr 20 05:37 PM
GRAY MARY ANNDirectorApr 07Option Exercise1.33132,839176,600132,839Apr 07 08:27 PM
BAKER BROS. ADVISORS LPDirectorApr 01Buy28.52302,9008,638,57221,167,398Apr 01 04:21 PM
BAKER BROS. ADVISORS LPDirectorMar 31Buy27.21683,64418,601,18020,894,327Apr 01 04:21 PM
BAKER BROS. ADVISORS LPDirectorMar 30Buy25.94462,54612,000,0562,799,646Apr 01 04:21 PM
Baity GlennEVP AND GCMar 02Option Exercise15.377,000107,59069,921Mar 04 04:54 PM
Baity GlennEVP AND GCMar 02Sale20.807,000145,58062,921Mar 04 04:54 PM